Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
| 18 Feb 2025 | |
| WIB-Metro New York News |
| WIB-Metro New York |
Our sold-out event on February 6th at Biolabs@NYULangone in New York City brought together over 60 professionals for an exciting discussion on AI’s disruptive impact on the life sciences. The evening was a perfect mix of learning, networking, and thought-provoking conversation. The event kicked off with a packed room eager to dive into the conversation. Dr. Glennis Mehra, Director of Biolabs@NYULangone, expertly moderated a panel featuring Dr. Maria Luisa Pineda, CEO & Co-Founder of Envisagenics; Jessily R., Founder of CureAIInsights; and Logan Troppito, Senior Manager at Accenture. Together, they broke down how AI is reshaping drug development, streamlining drug launches, and transforming logistics in the industry. The discussion sparked fascinating insights, with attendees especially drawn to the opportunities and challenges AI brings to drug discovery and the life sciences. After the panel, the night continued with great networking, as professionals and colleagues connected over shared interests and ideas.
Submitted by Wendy Diller
To view the Photo Gallery
